Dyonmed SA., the first Greek company with POINT OF CARE tests and procedures, innovates again and introduces:
No more than 2 drops of blood and 15 minutes are enough to have Negative coincidence rate > 97.5% vs PCR.
SARS-CoV-2 IgM/IgG Antibody Rapid Test Device.
SARS-CoV 2 (COVID-19), it is a novel coronavirus with new strain that has not been previously identified in humans, belongs to Coronaviruses (CoV) such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
This kit DyonCovid19® is an immunochromatographic assay, using capture method for rapid, qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgM/IgG antibody in human serum, plasma or whole blood sample.
Easy to use
Sensitivity and Specificity
Analysis of coincidence rate of SARS-CoV-2 IgM Ab rapid test and PCR Test in serum samples:
- Positive coincidence rate=246 / (246+54) × 100% = 82%
- Negative coincidence rate=960 / (40+960) × 100% = 96%
Total coincidence rate=(246+960) / (246+54+40+960) × 100% = 92.8%.
Analysis of coincidence rate of SARS-CoV-2 IgG Ab rapid test and PCR Test in serum samples:
- Positive coincidence rate=279 / (279+21) × 100% = 93%
- Negative coincidence rate=975 / (25+975) × 100% = 97.5%
Total coincidence rate=(279+975) / (279+21+25+975) × 100% = 96.5%.
Find the patient profile you are interested in
Learn more about
One drop | Direct control | Suitable for population control
Patient profile for application DyonCovid19-S